Company profile
Key2Brain AB
Next Generation Brain Targeting Therapies
- Industry
- Biotechnology
- Employees
- 14
- Headquarters
- Stockholm
- Founded
- 2020
- Office locations
- 1
Key2Brain AB company summary
Key2Brain AB is a company in the Biotechnology industry, headquartered in Stockholm, founded in 2020. On LinkedIn the company has around 14 employees.
What technology does Key2Brain AB use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Key2Brain AB
Key2Brain is a Swedish biotechnology company dedicated to developing next generation brain targeting therapies utilizing its proprietary blood-brain barrier-crossing technology. The technology enables efficient brain uptake and broad distribution into the brain and can be integrated into a wide range of therapeutic molecules. The pipeline is being developed internally and in partnerships where Key2Brain’s team leverages extensive industry experience in biologics and brain-targeting drugs, accelerating the translation from discovery to the clinic.
Where is Key2Brain AB located?
Key2Brain AB lists 1 location.
Compare companies similar to Key2Brain AB
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Key2Brain AB key2brain.com | Biotechnology | 14 | 2020 | Stockholm |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Key2Brain AB
What does Key2Brain AB do?
Key2Brain is a Swedish biotechnology company dedicated to developing next generation brain targeting therapies utilizing its proprietary blood-brain barrier-crossing technology. The technology enables efficient brain uptake and broad distribution into the brain and can be integrated into a wide range of therapeutic molecules. The pipeline is being developed internally and in partnerships where Key2Brain’s team leverages extensive industry experience in biologics and brain-targeting drugs, accelerating the translation from discovery to the clinic.
How many employees does Key2Brain AB have?
Key2Brain AB has around 14 employees on LinkedIn.
Where is Key2Brain AB headquartered?
Key2Brain AB is headquartered in Stockholm.
When was Key2Brain AB founded?
Key2Brain AB was founded in 2020.
Build a lead list from companies like Key2Brain AB
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.